an Heart Therapeutics Appoints Charlotte Arnold As Chief Corporate Affairs Officer
09/28/23, 5:56 PM
Location
new york
Industry
biopharma
therapeutics
pharmaceutical
biotechnology
health care
Position
chief corporate affairs officer
NEW YORK–– AnHeart Therapeutics , a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, today announced the appointment of Charlotte Arnold as Chief Corporate Affairs Officer.
Company Info
Location
new york, new york, united states
Additional Info
AnHeart Therapeutics Ltd. is a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer. Their lead asset, taletrectinib, is a next-generation ROS1 inhibitor with potentially best-in-class profile aiming to overcome the limitations of existing therapies.